Coronavirus (COVID-19)

Even if they're wearing face masks, healthcare workers can still be quite leery of getting up close and personal with patients who may have COVID-19. That's where a new robotic system comes in, as it lets clinicians take samples at a distance.

New data has found the cheap steroid dexamethasone significantly reduces deaths when administered to COVID-19 patients in intensive care. The treatment has been described as “the first major breakthrough in the therapeutics of COVID-19 infection”.

Scientists in Italy have uncovered evidence of the coronavirus appearing in sewage months before the country confirmed its first cases, a finding that may help them understand the origins of the virus and how it spread throughout the country.

A study has found antibody levels in recovered COVID-19 patients dropped significantly two months after hospital discharge. The study does not suggest patients can rapidly be reinfected but does question how long immunity may last after one recovers.

Although N95 face masks are quite effective at blocking transmission of the COVID-19-causing SARS-CoV-2 virus, they're also intended to be used only a few times at most. A new removable membrane, however, could make them much more reusable.

Several authors behind a paper finding hydroxychloroquine ineffective as a COVID-19 treatment have requested it be retracted. Meanwhile, the first results from a clinical trial testing the drug found it's no better than placebo at preventing COVID-19.

A new study has concluded hydroxychloroquine treatment for COVID-19 is not safe or effective. The large-scale observational analysis encompassed nearly 100,000 subjects found the drug treatment increases risk of mortality and cardiovascular events.

Photography social network Agora’s latest photo contest tasked its community with capturing unique perspectives on the extraordinary worldwide lockdown. The results offer a diverse portrait of people from all over the world sharing a strange experience.

Hot on the heels of biotech company Moderna’s recent announcement of successful phase 1 trials for its mRNA COVID-19 vaccine, two more promising candidates are delivering encouraging early data as several vaccines race into phase 2 human testing.

The lockdown orders implemented around the globe to control the spread of the novel coronavirus have led to a dramatic dip in some airborne pollutants, and a new study has revealed that carbon dioxide emissions have followed a similar trend.

A choir rehearsal, a series of family gatherings, and a multi-day church event. Three CDC reports offer detailed insights into super-spreader COVID-19 clusters. Can these reports point us towards safer ways to reopen our communities?

Illustrating the incredibly rapid pace of COVID-19 vaccine development, biotech company Moderna has revealed data from its Phase 1 human trials showing its experimental vaccine is safe, well-tolerated and generates significant antibody levels.